Profil
Bruce P.
Connop is an Independent Director at IBEX Technologies, Inc. since 2017.
He is also the Vice President-Preclinical Research & Development at Active Pass Pharmaceuticals, Inc. since 1999.
Previously, he worked as the VP-Non Clinical & Pharmaceutical Development at Transition Therapeutics, Inc. from 2006 to 2012.
Dr. Connop holds a doctorate degree from Queen's University.
Aktive Positionen von Bruce P. Connop
| Unternehmen | Position | Beginn |
|---|---|---|
| IBEX TECHNOLOGIES | Direktor/Vorstandsmitglied | 11.10.2017 |
Active Pass Pharmaceuticals, Inc.
Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for infectious diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1999 |
Ehemalige bekannte Positionen von Bruce P. Connop
| Unternehmen | Position | Ende |
|---|---|---|
| TRANSITION THERAPEUTICS INC | Corporate Officer/Principal | - |
Ausbildung von Bruce P. Connop
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Transition Therapeutics, Inc.
Transition Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical development company that manufactures novel therapeutics for CNS, metabolic diseases and androgen deficiency indications | Commercial Services |
IBEX Technologies, Inc.
IBEX Technologies, Inc. Pharmaceuticals: OtherHealth Technology Develops and manufactures specialty enzymes, diagnostic reagents & biomedical products | Health Technology |
Queen's University
Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Active Pass Pharmaceuticals, Inc.
Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for infectious diseases | Health Technology |
















